PNC Financial Services Group
CASI

PNC Financial Services Group’s CASI Pharmaceuticals CASI Stock Holding History

PNC Financial Services Group’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed – – 4113
2020
Q4 		$0 Buy
+2
New +$43 ﹤0.01% 3970

Other funds holding CASI

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
TLP
Tri Locum Partners New York $713M AUM 68.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's CASI Position: Q1 2021 in Review

PNC Financial Services Group sold out of CASI Pharmaceuticals (CASI) in Q1 2021, closing a stake of 2 shares.

PNC Financial Services Group first reported a position in CASI in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 85 funds tracked by Wall St. Rank hold CASI as of Q1 2021.

  • PNC Financial Services Group reported no remaining CASI Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 2 CASI Pharmaceuticals shares in Q1 2021.
  • PNC Financial Services Group first reported a position in CASI Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • PNC Financial Services Group's CASI Pharmaceuticals position peaked at $0 in Q4 2020.
  • 85 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2021.

Based on PNC Financial Services Group's 13F filing for Q1 2021, filed 7 May 2021.